欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3398/007
药品名称Trigelan 200 mg/50 mg/200 mg film-coated tablets
活性成分
    • carbidopa 50.0 mg
    • entacapone 200.0 mg
    • levodopa 200.0 mg
剂型Film-coated tablet
上市许可持有人G.L. Pharma GmbH Schlossplatz 1, Lannach 8502, Austria
参考成员国 - 产品名称Netherlands (NL)
Levodopa/Carbidopa/Entacapone Lannacher 200 mg/50 mg/200 mg filmomhulde tabletten
互认成员国 - 产品名称
    • Austria (AT)
      Trigelan 200 mg/50 mg/200 mg-Filmtabletten
    • Hungary (HU)
      TRIGELAN 200 mg/50 mg/200 mg filmtabletta
    • Czechia (CZ)
      Trigelan 200 mg/ 50 mg/ 200 mg potahované tablety
    • Romania (RO)
      Trigelan 200 mg/50 mg/200 mg comprimate filmate
    • Slovakia (SK)
      Trigelan 200 mg/50 mg/200 mg filmom obalené tablety
许可日期2015/12/03
最近更新日期2023/07/07
药物ATC编码
    • N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase